Molecular imaging has emerged as a promising adjunct for the evaluation of pituitary neuroendocrine tumors (PitNETs), as magnetic resonance imaging (MRI), despite being the primary imaging modality, remains inconclusive in a substantial proportion of patients.... ...

请注册登录后继续浏览